StockMacro
Menu

Healthpeak Properties

$19.24 -3.9% in 6 monthsMarket cap $13.3B

DOC on XNYS, Real Estate, Healthpeak Properties, Inc., job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 16% to $821M and shares gained 11% in 12 months.

  • GoodTrailing 12-month revenue up 9.4% to $3.1B

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.

Industry
Real estate investment trusts (Real Estate)
Employees
411
Website
healthpeak.com
Listed
NYSE, US
Last results
2 Nov 2026
Next results
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $820.9M, net income $17.3M.
Quarter to 31 Dec 2021: revenue $483.2M, net income $28.8MQuarter to 31 Dec 2021: revenue $483.2M, net income $28.8MQuarter to 31 Mar 2022: revenue $498.4M, net income $71.6MQuarter to 31 Mar 2022: revenue $498.4M, net income $71.6MQuarter to 30 Jun 2022: revenue $517.9M, net income $68.3MQuarter to 30 Jun 2022: revenue $517.9M, net income $68.3MQuarter to 30 Sep 2022: revenue $520.4M, net income $354.0MQuarter to 30 Sep 2022: revenue $520.4M, net income $354.0MQuarter to 31 Dec 2022: revenue $524.5M, net income $6.5MQuarter to 31 Dec 2022: revenue $524.5M, net income $6.5MQuarter to 31 Mar 2023: revenue $525.7M, net income $119.0MQuarter to 31 Mar 2023: revenue $525.7M, net income $119.0MQuarter to 30 Jun 2023: revenue $545.4M, net income $51.9MQuarter to 30 Jun 2023: revenue $545.4M, net income $51.9MQuarter to 30 Sep 2023: revenue $556.2M, net income $64.2MQuarter to 30 Sep 2023: revenue $556.2M, net income $64.2MQuarter to 31 Dec 2023: revenue $553.7M, net income $70.9MQuarter to 31 Dec 2023: revenue $553.7M, net income $70.9MQuarter to 31 Mar 2024: revenue $606.6M, net income $6.7MQuarter to 31 Mar 2024: revenue $606.6M, net income $6.7MQuarter to 30 Jun 2024: revenue $695.5M, net income $146.0MQuarter to 30 Jun 2024: revenue $695.5M, net income $146.0MQuarter to 30 Sep 2024: revenue $700.4M, net income $85.9MQuarter to 30 Sep 2024: revenue $700.4M, net income $85.9MQuarter to 31 Dec 2024: revenue $698.0M, net income $4.5MQuarter to 31 Dec 2024: revenue $698.0M, net income $4.5MQuarter to 31 Mar 2025: revenue $702.9M, net income $42.8MQuarter to 31 Mar 2025: revenue $702.9M, net income $42.8MQuarter to 30 Jun 2025: revenue $694.3M, net income $31.7MQuarter to 30 Jun 2025: revenue $694.3M, net income $31.7MQuarter to 30 Sep 2025: revenue $705.9M, net income -$117.1MQuarter to 30 Sep 2025: revenue $705.9M, net income -$117.1MQuarter to 31 Dec 2025: revenue $719.4M, net income $114.0MQuarter to 31 Dec 2025: revenue $719.4M, net income $114.0MQuarter to 31 Mar 2026: revenue $753.0M, net income $193.6MQuarter to 31 Mar 2026: revenue $753.0M, net income $193.6MQuarter to 30 Jun 2026: revenue $771.6M, net income $52.8MQuarter to 30 Jun 2026: revenue $771.6M, net income $52.8MQuarter to 30 Sep 2026: revenue $820.9M, net income $17.3MQuarter to 30 Sep 2026: revenue $820.9M, net income $17.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $820.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$820.9M$17.3M
30 Jun 2026$771.6M$52.8M
31 Mar 2026$753.0M$193.6M
31 Dec 2025$719.4M$114.0M
30 Sep 2025$705.9M-$117.1M
30 Jun 2025$694.3M$31.7M
31 Mar 2025$702.9M$42.8M
31 Dec 2024$698.0M$4.5M
30 Sep 2024$700.4M$85.9M
30 Jun 2024$695.5M$146.0M
31 Mar 2024$606.6M$6.7M
31 Dec 2023$553.7M$70.9M
30 Sep 2023$556.2M$64.2M
30 Jun 2023$545.4M$51.9M
31 Mar 2023$525.7M$119.0M
31 Dec 2022$524.5M$6.5M
30 Sep 2022$520.4M$354.0M
30 Jun 2022$517.9M$68.3M
31 Mar 2022$498.4M$71.6M
31 Dec 2021$483.2M$28.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $3.1B $2.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +9.4% +5.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $377.7M -$38.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.54 -$0.06
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – 60.1% 68.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – 37.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 12.3% -1.4% 14.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 4.9% 4.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $514.3M $91.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 1.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $11.41
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 35.1 24.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 4.3 4.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 9.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.7 1.1
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 6.3% 5.1%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Healthpeak PropertiesDOC (this company) $13.3B35.14.3+9.4%12.3%
Annaly Capital Management.NLY $13.3B11.9–––
American Healthcare REITAHR $13.4B1395.0+21%3.6%
Mid-America Apartment CommunitiesMAA $13.1B33.65.9+0.8%17.6%
Regency CentersREG $13.5B24.78.5+7.8%34.5%
Sun CommunitiesSUI $13.7Bloss5.9+2.9%-32.9%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$127K

bought $0, sold $127K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.3%

756 13F filers vs 739

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

94%

649.3M shares held by 13F filers (30 Sep 2026) of 689.5M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.3%

22.9M shares sold short (30 Oct 2026) of 689.5M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.0

22.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.2%

21.7M shares sold short in the report before, 22.9M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

61%

61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 53%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+16%

$820.9M vs $705.9M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$60K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

23

23 articles in the last 7 days; its usual week has 4 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.8×

23 articles in the last 7 days; its usual week has 4.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Revenue $268.3M, 1.8× a year earlier

Price $19.24 on 20 Nov 2026, +11% over 12 months (12-month range $15.78 to $22.82)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $341K in the last 12 months (the 12 months before: $1.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $820.9M in the latest quarter, +16% on a year earlier.
Institutional holders (13F filers). 756 13F filers reported holding it in the latest 13F quarter, +6.6% on a year earlier.
Lobbying spend. Lobbying spend: $60K published in the last 12 months, -69% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: capital spending per quarter, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Nov 2026Sharp changeQuarterly revenue change: quarterly revenue change, 268.3M vs usual 149.7M (2026-09-30); 1.8x the same period a year earlier
6 Aug 2026Sharp changeQuarterly revenue change: quarterly revenue change, 216.5M vs usual 148.9M (2026-06-30); 1.5x the same period a year earlier
7 May 2026Sharp changeQuarterly revenue change: quarterly revenue change, 200.3M vs usual 147.4M (2026-03-31); 1.3x the same period a year earlier
3 Mar 2026Sharp changeShort interest spike: short interest spike, 31.2M vs usual 17.5M (2026-02-13); 2.3x the same period a year earlier
17 Feb 2026Sharp changeShort interest spike: short interest spike, 27.3M vs usual 16.8M (2026-01-30); 2.2x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 20.7M vs usual 11.2M (2025-06-13); 1.8x the same period a year earlier
29 Apr 2025Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 631K)
28 Apr 20258-K and other filingsDirector or officer change
24 Apr 20258-K and other filingsDirector or officer change
7 Apr 20258-K and other filingsDirector or officer change
1 Apr 2025Sharp changeShort interest spike: short interest spike, 15.8M vs usual 11.0M (2025-03-14); 1.6x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 15.5M vs usual 10.9M (2025-02-28); 2.9x the same period a year earlier
3 Feb 20258-K and other filingsDirector or officer change
3 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 118 vs usual 57 (2024-03-31); 2.6x the same period a year earlier
26 Apr 20248-K and other filingsDirector or officer change
1 Mar 20248-K and other filingsDirector or officer change
1 Mar 20248-K and other filingsCompleted an acquisition or asset sale
1 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Apr 20238-K and other filingsDirector or officer change
17 Mar 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 506K)
14 Mar 20238-K and other filingsDirector or officer change
14 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Nov 20228-K and other filingsDirector or officer change
6 Oct 20228-K and other filingsDirector or officer change
6 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jul 20228-K and other filingsDirector or officer change
6 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: -$10K published
Month from 1 Nov 2022: -$46K published
Month from 1 Dec 2022: -$25K published
Month from 1 Feb 2023: -$31K published
Month from 1 Mar 2023: $506K published
Month from 1 Mar 2024: $301K published
Month from 1 Apr 2025: $720K published
Month from 1 May 2025: $247K published
Month from 1 Jul 2025: $50K published
Month from 1 Aug 2025: $100K published
Month from 1 May 2026: -$214K published
Month from 1 Nov 2026: -$127K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $483.2M, +12% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $498.4M, +9.5% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $517.9M, +8.8% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $520.4M, +8.1% on a year earlier; public on 3 Nov 2022
Quarter ended 31 Dec 2022: $524.5M, +8.5% on a year earlier; public on 9 Feb 2023
Quarter ended 31 Mar 2023: $525.7M, +5.5% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $545.4M, +5.3% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $556.2M, +6.9% on a year earlier; public on 31 Oct 2023
Quarter ended 31 Dec 2023: $553.7M, +5.6% on a year earlier; public on 10 Feb 2024
Quarter ended 31 Mar 2024: $606.6M, +15% on a year earlier; public on 27 Apr 2024
Quarter ended 30 Jun 2024: $695.5M, +28% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $700.4M, +26% on a year earlier; public on 26 Oct 2024
Quarter ended 31 Dec 2024: $698.0M, +26% on a year earlier; public on 5 Feb 2025
Quarter ended 31 Mar 2025: $702.9M, +16% on a year earlier; public on 26 Apr 2025
Quarter ended 30 Jun 2025: $694.3M, -0.2% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $705.9M, +0.8% on a year earlier; public on 25 Oct 2025
Quarter ended 31 Dec 2025: $719.4M, +3.1% on a year earlier; public on 4 Feb 2026
Quarter ended 31 Mar 2026: $753.0M, +7.1% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $771.6M, +11% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $820.9M, +16% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 541; public on 14 Feb 2022
31 Mar 2022 report: 589; public on 16 May 2022
30 Jun 2022 report: 568; public on 15 Aug 2022
30 Sep 2022 report: 530; public on 14 Nov 2022
31 Dec 2022 report: 550; public on 14 Feb 2023
31 Mar 2023 report: 534; public on 15 May 2023
30 Jun 2023 report: 548; public on 14 Aug 2023
30 Sep 2023 report: 533; public on 14 Nov 2023
31 Dec 2023 report: 566; public on 14 Feb 2024
31 Mar 2024 report: 633; public on 15 May 2024
30 Jun 2024 report: 663; public on 14 Aug 2024
30 Sep 2024 report: 681; public on 14 Nov 2024
31 Dec 2024 report: 718; public on 14 Feb 2025
31 Mar 2025 report: 714; public on 15 May 2025
30 Jun 2025 report: 688; public on 14 Aug 2025
30 Sep 2025 report: 709; public on 14 Nov 2025
31 Dec 2025 report: 732; public on 17 Feb 2026
31 Mar 2026 report: 740; public on 15 May 2026
30 Jun 2026 report: 739; public on 14 Aug 2026
30 Sep 2026 report: 756; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $22K published
Quarter from 1 Apr 2022: $22K published
Quarter from 1 Jul 2022: $22K published
Quarter from 1 Oct 2022: $22K published
Quarter from 1 Jan 2023: $22K published
Quarter from 1 Apr 2023: $24K published
Quarter from 1 Jul 2023: $27K published
Quarter from 1 Oct 2023: $27K published
Quarter from 1 Jan 2024: $27K published
Quarter from 1 Apr 2024: $27K published
Quarter from 1 Jul 2024: $27K published
Quarter from 1 Oct 2024: $27K published
Quarter from 1 Jan 2025: $27K published
Quarter from 1 Apr 2025: $49K published
Quarter from 1 Jul 2025: $60K published
Quarter from 1 Oct 2025: $60K published
Quarter from 1 Oct 2026: $60K published

What is unusual now

  • Made public in the last 90 days: it reported revenue of $268.3M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year.
  • Quarterly revenue change: reported revenue of $268.3M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year Public on 5 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $341K in the last 12 months (the 12 months before: $1.1M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 50 insider trades

Last 90 days: 1 sale, $127K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Nov 2026Ankit B. PatadiaEVP and TreasurerSell6,115$20.78$127KForm 4
13 May 2026Scott R BohnCDO and Head of LabSell10,989$19.45$214KForm 4
6 Aug 2025John T ThomasDirectorBuy1,450$17.06$25KForm 4
4 Aug 2025Scott M BrinkerPresident and CEOBuy1,490$16.83$25KForm 4
31 Jul 2025Scott M BrinkerPresident and CEOBuy2,930$17.06$50KForm 4
29 Jul 2025Scott M BrinkerPresident and CEOBuy2,873$17.40$50KForm 4
28 May 2025Tommy G ThompsonDirectorBuy5,777$17.27$100KForm 4
12 May 2025Tommy G ThompsonDirectorBuy5,700$17.36$99KForm 4

756 institutions reported shares at the end of Q3 2026, 94% of the shares outstanding; 86 opened a position, 70 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.83.7M12.1%$1.7B+12.8M+18%
Vanguard Portfolio Management LLC57.8M8.38%$1.2B-575K-1.0%
Vanguard Capital Management LLC45.2M6.55%$902.3M+168K+0.4%
State Street Corp44.4M6.44%$887.0M+410K+0.9%
Geode Capital Management, LLC25.8M3.74%$514.1M+1.1M+4.5%
JPMorgan Chase & Co23.7M3.43%$477.4M-6.5M-22%
Invesco Ltd.21.5M3.12%$429.4M+3.0M+16%
Fuller & Thaler Asset Management, Inc.20.8M3.02%$416.0M-8.3M-28%
Bank of New York Mellon Corp18.2M2.64%$363.3M+3.0M+19%
Principal Financial Group Inc14.8M2.15%$296.0M-1.9M-12%

Company events

All 47 company events

In 12 months: 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
23 Mar 2026Signed a major agreementSame filing: took on new debt8-K
28 Apr 2025Director or officer changeSame filing: shareholder vote results8-K
24 Apr 2025Director or officer change8-K
7 Apr 2025Director or officer change8-K
3 Feb 2025Director or officer change8-K
9 Dec 2024Signed a major agreementSame filing: took on new debt8-K
26 Apr 2024Director or officer changeSame filing: shareholder vote results8-K
11 Mar 2024Signed a major agreement8-K

Reported lobbying spend: $60K in Q3 2026, $60K in Q3 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jan 2018NewMarshall Brachmanfor Healthpeak Properties, Inc. Fka Physicians Realty Trustmonitor for tax issues affecting real estate investment trusts general health care policy affecting hospitals and physician practicesTaxation, Health issuesFiling

The 5 newest of 250 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

29 Apr 2025confirmed

Confirmed across sources Insiders and Short interest and volume

Healthpeak Properties (DOC): had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year, while it had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 27 days.

  • Short interest and volume: Short interest spike, became public on 26 Mar 2025
  • Insiders: Clustered insider buying, became public on 29 Apr 2025
2024-03-15: 9.7M2024-03-28: 10.7M2024-04-15: 10.6M2024-04-30: 11.2M2024-05-15: 12.8M2024-05-31: 12.0M2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M
The 14 Mar 2025 report against the 24 reports before it. this reportearliernormal: 11.0M
See the evidence (2 changes)

Short interest and volume: Short interest spike became public on 26 Mar 2025

Healthpeak Properties had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.

This period
15.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
11.0M
Typical spread (median absolute deviation)
713K
How far from its usual level
+4.4
Same report last year
9.7M
History used
2,632 days
2024-03-15: 9.7M2024-03-28: 10.7M2024-04-15: 10.6M2024-04-30: 11.2M2024-05-15: 12.8M2024-05-31: 12.0M2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M
the 14 Mar 2025 report24 earlier reportsnormal: 11.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 29 Apr 2025

Healthpeak Properties had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings).

Independent buyers
5
Purchase filings (Form 4, code P)
5
Total bought
$631K
Window
30 Mar 2025 to 29 Apr 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

7 May 2019confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Healthpeak Properties (DOC): had 9.0M shares sold short in the 29 Mar 2019 report, 2.2× the same report last year, while it reported revenue of $126.7M for the quarter ended 31 Mar 2019, 74% below the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 10 Apr 2019
  • Short interest and volume: Short interest spike, became public on 26 Apr 2019
  • Financials: Quarterly revenue change, became public on 7 May 2019
  • Short interest and volume: Short interest spike, became public on 10 May 2019
2018-03-29: 4.2M2018-04-13: 4.5M2018-04-30: 4.9M2018-05-15: 4.4M2018-05-31: 4.0M2018-06-15: 4.5M2018-06-29: 5.3M2018-07-13: 5.2M2018-07-31: 4.3M2018-08-15: 4.4M2018-08-31: 5.4M2018-09-14: 5.5M2018-09-28: 5.7M2018-10-15: 5.6M2018-10-31: 4.8M2018-11-15: 3.8M2018-11-30: 5.0M2018-12-14: 5.6M2018-12-31: 5.6M2019-01-15: 5.7M2019-01-31: 4.2M2019-02-15: 4.3M2019-02-28: 4.6M2019-03-15: 7.9M2019-03-29: 9.0M
The 29 Mar 2019 report against the 24 reports before it. this reportearliernormal: 4.8M
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 10 Apr 2019

Healthpeak Properties had 9.0M shares sold short in the 29 Mar 2019 report, 2.2× the same report last year.

This period
9.0M (the 29 Mar 2019 report)
Normal report (median of 24 earlier)
4.8M
Typical spread (median absolute deviation)
569K
How far from its usual level
+4.9
Same report last year
4.2M
History used
455 days
2018-03-29: 4.2M2018-04-13: 4.5M2018-04-30: 4.9M2018-05-15: 4.4M2018-05-31: 4.0M2018-06-15: 4.5M2018-06-29: 5.3M2018-07-13: 5.2M2018-07-31: 4.3M2018-08-15: 4.4M2018-08-31: 5.4M2018-09-14: 5.5M2018-09-28: 5.7M2018-10-15: 5.6M2018-10-31: 4.8M2018-11-15: 3.8M2018-11-30: 5.0M2018-12-14: 5.6M2018-12-31: 5.6M2019-01-15: 5.7M2019-01-31: 4.2M2019-02-15: 4.3M2019-02-28: 4.6M2019-03-15: 7.9M2019-03-29: 9.0M
the 29 Mar 2019 report24 earlier reportsnormal: 4.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Apr 2019

Healthpeak Properties had 8.6M shares sold short in the 15 Apr 2019 report, 1.9× the same report last year.

This period
8.6M (the 15 Apr 2019 report)
Normal report (median of 24 earlier)
4.9M
Typical spread (median absolute deviation)
618K
How far from its usual level
+4.0
Same report last year
4.5M
History used
472 days
2018-04-13: 4.5M2018-04-30: 4.9M2018-05-15: 4.4M2018-05-31: 4.0M2018-06-15: 4.5M2018-06-29: 5.3M2018-07-13: 5.2M2018-07-31: 4.3M2018-08-15: 4.4M2018-08-31: 5.4M2018-09-14: 5.5M2018-09-28: 5.7M2018-10-15: 5.6M2018-10-31: 4.8M2018-11-15: 3.8M2018-11-30: 5.0M2018-12-14: 5.6M2018-12-31: 5.6M2019-01-15: 5.7M2019-01-31: 4.2M2019-02-15: 4.3M2019-02-28: 4.6M2019-03-15: 7.9M2019-03-29: 9.0M2019-04-15: 8.6M
the 15 Apr 2019 report24 earlier reportsnormal: 4.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 7 May 2019

Healthpeak Properties reported revenue of $126.7M for the quarter ended 31 Mar 2019, 74% below the same quarter last year.

This period
$126.7M (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
$457.5M
Typical spread (median absolute deviation)
$13.1M
How far from its usual level
-7.2
Same quarter last year
$479.2M
History used
3,926 days
2017-03-31: $492.2M2017-06-30: $458.9M2017-09-30: $454.0M2017-12-31: $443.3M2018-03-31: $479.2M2018-06-30: $469.6M2018-09-30: $456.0M2018-12-31: $441.9M2019-03-31: $126.7M
the quarter ended 31 Mar 20198 earlier quartersnormal: $457.5M

Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 10 May 2019

Healthpeak Properties had 8.5M shares sold short in the 30 Apr 2019 report, 1.7× the same report last year.

This period
8.5M (the 30 Apr 2019 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
565K
How far from its usual level
+4.0
Same report last year
4.9M
History used
487 days
2018-04-30: 4.9M2018-05-15: 4.4M2018-05-31: 4.0M2018-06-15: 4.5M2018-06-29: 5.3M2018-07-13: 5.2M2018-07-31: 4.3M2018-08-15: 4.4M2018-08-31: 5.4M2018-09-14: 5.5M2018-09-28: 5.7M2018-10-15: 5.6M2018-10-31: 4.8M2018-11-15: 3.8M2018-11-30: 5.0M2018-12-14: 5.6M2018-12-31: 5.6M2019-01-15: 5.7M2019-01-31: 4.2M2019-02-15: 4.3M2019-02-28: 4.6M2019-03-15: 7.9M2019-03-29: 9.0M2019-04-15: 8.6M2019-04-30: 8.5M
the 30 Apr 2019 report24 earlier reportsnormal: 5.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 5 Nov 2026Financials change

    reported revenue of $268.3M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year.

    Same quarter last year: $150.5M; its normal quarter is $149.7M.

    See the evidence
    This period
    $268.3M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $149.7M
    Typical spread (median absolute deviation)
    $4.9M
    How far from its usual level
    +7.9
    Same quarter last year
    $150.5M
    History used
    3,835 days
    2024-09-30: $142.8M2024-12-31: $146.0M2025-03-31: $148.9M2025-06-30: $148.9M2025-09-30: $150.5M2025-12-31: $155.7M2026-03-31: $200.3M2026-06-30: $216.5M2026-09-30: $268.3M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $149.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 6 Aug 2026Financials change

    reported revenue of $216.5M for the quarter ended 30 Jun 2026, 1.5× the same quarter last year.

    Same quarter last year: $148.9M; its normal quarter is $148.9M.

    See the evidence
    This period
    $216.5M (the quarter ended 30 Jun 2026)
    Normal quarter (median of 8 earlier)
    $148.9M
    Typical spread (median absolute deviation)
    $4.5M
    How far from its usual level
    +4.5
    Same quarter last year
    $148.9M
    History used
    3,743 days
    2024-06-30: $140.9M2024-09-30: $142.8M2024-12-31: $146.0M2025-03-31: $148.9M2025-06-30: $148.9M2025-09-30: $150.5M2025-12-31: $155.7M2026-03-31: $200.3M2026-06-30: $216.5M
    the quarter ended 30 Jun 20268 earlier quartersnormal: $148.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  3. 7 May 2026Financials change

    reported revenue of $200.3M for the quarter ended 31 Mar 2026, 1.3× the same quarter last year.

    Same quarter last year: $148.9M; its normal quarter is $147.4M.

    See the evidence
    This period
    $200.3M (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    $147.4M
    Typical spread (median absolute deviation)
    $3.8M
    How far from its usual level
    +3.6
    Same quarter last year
    $148.9M
    History used
    3,652 days
    2024-03-31: $138.8M2024-06-30: $140.9M2024-09-30: $142.8M2024-12-31: $146.0M2025-03-31: $148.9M2025-06-30: $148.9M2025-09-30: $150.5M2025-12-31: $155.7M2026-03-31: $200.3M
    the quarter ended 31 Mar 20268 earlier quartersnormal: $147.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  4. 26 Feb 2026Short interest and volume change

    had 31.2M shares sold short in the 13 Feb 2026 report, 2.3× the same report last year.

    Same report last year: 13.8M; its normal report is 17.5M.

    See the evidence
    This period
    31.2M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    17.5M
    Typical spread (median absolute deviation)
    2.4M
    How far from its usual level
    +3.8
    Same report last year
    13.8M
    History used
    2,968 days
    2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M2025-03-31: 14.8M2025-04-15: 15.4M2025-04-30: 14.9M2025-05-15: 16.3M2025-05-30: 14.9M2025-06-13: 20.7M2025-06-30: 20.2M2025-07-15: 19.2M2025-07-31: 21.0M2025-08-15: 17.7M2025-08-29: 17.4M2025-09-15: 15.9M2025-09-30: 15.3M2025-10-15: 15.6M2025-10-31: 18.6M2025-11-14: 19.8M2025-11-28: 21.5M2025-12-15: 22.0M2025-12-31: 24.3M2026-01-15: 25.6M2026-01-30: 27.3M2026-02-13: 31.2M
    the 13 Feb 2026 report24 earlier reportsnormal: 17.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Feb 2026Short interest and volume change

    had 27.3M shares sold short in the 30 Jan 2026 report, 2.2× the same report last year.

    Same report last year: 12.3M; its normal report is 16.8M.

    See the evidence
    This period
    27.3M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    16.8M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +3.6
    Same report last year
    12.3M
    History used
    2,954 days
    2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M2025-03-31: 14.8M2025-04-15: 15.4M2025-04-30: 14.9M2025-05-15: 16.3M2025-05-30: 14.9M2025-06-13: 20.7M2025-06-30: 20.2M2025-07-15: 19.2M2025-07-31: 21.0M2025-08-15: 17.7M2025-08-29: 17.4M2025-09-15: 15.9M2025-09-30: 15.3M2025-10-15: 15.6M2025-10-31: 18.6M2025-11-14: 19.8M2025-11-28: 21.5M2025-12-15: 22.0M2025-12-31: 24.3M2026-01-15: 25.6M2026-01-30: 27.3M
    the 30 Jan 2026 report24 earlier reportsnormal: 16.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 7 Aug 2025Insiders record

    Thomas John T (director) bought 1,450 shares of DOC ($24,737) (dated 6 Aug 2025)

  7. 5 Aug 2025Insiders record

    Brinker Scott M (President and CEO) bought 1,490 shares of DOC ($25,077) (dated 4 Aug 2025)

  8. 1 Aug 2025Insiders record

    Brinker Scott M (President and CEO) bought 2,930 shares of DOC ($49,986) (dated 31 Jul 2025)

  9. 30 Jul 2025Insiders record

    Brinker Scott M (President and CEO) bought 2,873 shares of DOC ($49,990) (dated 29 Jul 2025)

  10. 26 Jun 2025Short interest and volume change

    had 20.7M shares sold short in the 13 Jun 2025 report, 1.8× the same report last year.

    Same report last year: 11.6M; its normal report is 11.2M.

    See the evidence
    This period
    20.7M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    11.2M
    Typical spread (median absolute deviation)
    1.6M
    How far from its usual level
    +4.1
    Same report last year
    11.6M
    History used
    2,723 days
    2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M2025-03-31: 14.8M2025-04-15: 15.4M2025-04-30: 14.9M2025-05-15: 16.3M2025-05-30: 14.9M2025-06-13: 20.7M
    the 13 Jun 2025 report24 earlier reportsnormal: 11.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 29 May 2025Insiders record

    Thompson Tommy G (director) bought 5,777 shares of DOC ($99,769) (dated 28 May 2025)

  12. 13 May 2025Insiders record

    Thompson Tommy G (director) bought 5,700 shares of DOC ($98,952) (dated 12 May 2025)

  13. 13 May 2025Insiders record

    Brinker Scott M (President and CEO) bought 2,750 shares of DOC ($47,822) (dated 12 May 2025)

  14. 30 Apr 2025Insiders record

    Lias-Booker Ava (director) bought 5,000 shares of DOC ($89,150) (dated 29 Apr 2025)

  15. 29 Apr 2025several at once

    had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year, while it had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings). Two unrelated kinds of activity within 27 days.

    See the evidence (2 changes)

    Short interest and volume: Short interest spike became public on 26 Mar 2025

    Healthpeak Properties had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.

    This period
    15.8M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    11.0M
    Typical spread (median absolute deviation)
    713K
    How far from its usual level
    +4.4
    Same report last year
    9.7M
    History used
    2,632 days
    2024-03-15: 9.7M2024-03-28: 10.7M2024-04-15: 10.6M2024-04-30: 11.2M2024-05-15: 12.8M2024-05-31: 12.0M2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M
    the 14 Mar 2025 report24 earlier reportsnormal: 11.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 29 Apr 2025

    Healthpeak Properties had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings).

    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $631K
    Window
    30 Mar 2025 to 29 Apr 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  16. 29 Apr 2025Insiders change

    had 5 insiders buy $631K of its shares on the open market within 30 days (5 filings).

    Who bought: Shelley-Kessler Pamela, Lewis Sara Grootwassink, Thomas John T, Sandstrom Katherine M and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $631K
    Window
    30 Mar 2025 to 29 Apr 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  17. 29 Apr 2025Insiders record

    Brinker Scott M (President and CEO) bought 11,337 shares of DOC ($200,438) (dated 28 Apr 2025)

  18. 29 Apr 2025Insiders record

    Sandstrom Katherine M (director) bought 11,288 shares of DOC ($199,233) (dated 28 Apr 2025)

  19. 29 Apr 2025Insiders record

    Thomas John T (director) bought 4,200 shares of DOC ($74,928) (dated 28 Apr 2025)

  20. 29 Apr 2025Insiders record

    Lewis Sara Grootwassink (director) bought 6,000 shares of DOC ($105,960) (dated 28 Apr 2025)

  21. 29 Apr 2025Insiders record

    SHELLEY-KESSLER PAMELA (director) bought 2,838 shares of DOC ($50,006) (dated 28 Apr 2025)

  22. 28 Apr 2025Filings record

    Director or officer change

  23. 24 Apr 2025Filings record

    Director or officer change

  24. 7 Apr 2025Filings record

    Director or officer change

  25. 26 Mar 2025Short interest and volume change

    had 15.8M shares sold short in the 14 Mar 2025 report, 1.6× the same report last year.

    Same report last year: 9.7M; its normal report is 11.0M.

    See the evidence
    This period
    15.8M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    11.0M
    Typical spread (median absolute deviation)
    713K
    How far from its usual level
    +4.4
    Same report last year
    9.7M
    History used
    2,632 days
    2024-03-15: 9.7M2024-03-28: 10.7M2024-04-15: 10.6M2024-04-30: 11.2M2024-05-15: 12.8M2024-05-31: 12.0M2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M2025-03-14: 15.8M
    the 14 Mar 2025 report24 earlier reportsnormal: 11.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 12 Mar 2025Short interest and volume change

    had 15.5M shares sold short in the 28 Feb 2025 report, 2.9× the same report last year.

    Same report last year: 5.4M; its normal report is 10.9M.

    See the evidence
    This period
    15.5M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    10.9M
    Typical spread (median absolute deviation)
    652K
    How far from its usual level
    +4.3
    Same report last year
    5.4M
    History used
    2,618 days
    2024-02-29: 5.4M2024-03-15: 9.7M2024-03-28: 10.7M2024-04-15: 10.6M2024-04-30: 11.2M2024-05-15: 12.8M2024-05-31: 12.0M2024-06-14: 11.6M2024-06-28: 10.3M2024-07-15: 9.8M2024-07-31: 8.1M2024-08-15: 11.0M2024-08-30: 10.3M2024-09-13: 9.5M2024-09-30: 9.5M2024-10-15: 10.3M2024-10-31: 9.0M2024-11-15: 11.0M2024-11-29: 11.4M2024-12-13: 11.2M2024-12-31: 11.1M2025-01-15: 11.3M2025-01-31: 12.3M2025-02-14: 13.8M2025-02-28: 15.5M
    the 28 Feb 2025 report24 earlier reportsnormal: 10.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 3 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 3 Feb 2025Filings record

    Director or officer change

  29. 15 May 2024Institutional holdings change

    saw 118 13F filers open a new position in the quarter ended 31 Mar 2024, 2.6× the same quarter last year.

    Same quarter last year: 45; its normal quarter is 57.

    See the evidence
    This period
    118 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    57
    Typical spread (median absolute deviation)
    8
    How far from its usual level
    +5.1
    Same quarter last year
    45
    History used
    1,644 days
    2022-03-31: 622022-06-30: 582022-09-30: 412022-12-31: 622023-03-31: 452023-06-30: 562023-09-30: 252023-12-31: 682024-03-31: 118
    the quarter ended 31 Mar 20248 earlier quartersnormal: 57

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  30. 13 May 2024Institutional holdings record

    FULLER & THALER ASSET MANAGEMENT, INC. opened a $320.0M position (2024Q1 13F)

  31. 26 Apr 2024Filings record

    Director or officer change

  32. 5 Mar 2024Insiders record

    Lewis Sara Grootwassink (director) bought 18,000 shares of DOC ($300,780) (dated 4 Mar 2024)

  33. 1 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 1 Mar 2024Filings record

    Director or officer change

  35. 1 Mar 2024Filings record

    Completed an acquisition or asset sale

  36. 27 Apr 2023Filings record

    Director or officer change

  37. 17 Mar 2023Insiders change

    had 3 insiders buy $506K of its shares on the open market within 30 days (3 filings).

    Who bought: Brinker Scott M, Klaritch Thomas, Lewis Sara Grootwassink.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $506K
    Window
    15 Feb 2023 to 17 Mar 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  38. 17 Mar 2023Insiders record

    Lewis Sara Grootwassink (director) bought 4,000 shares of PEAK ($85,720) (dated 16 Mar 2023)

  39. 14 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 14 Mar 2023Filings record

    Director or officer change

Showing the newest 40 of 105 entries; narrow the window or the kind of data to see older ones.

Not listed: 181 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000765880
Ticker
DOC
Domain
healthpeak.com
Employer name
Healthpeak Properties, LLC (1 unverified)
Fein
92-1002851 (1 unverified)
Hq location
CO|DENVER|80237 (1 unverified)
Lobbying client
healthpeak properties inc fka physicians realty trust
Name
100 Discovery Park DE, LLC, 101 CPD LLC, 1040-1050 Waltham Street Lender, LLC, 3020-3030 Callan Road JV, L.L.C and 1323 more
Wikidata
Q16975567
Wikipedia
Healthpeak Properties
  • DOL H-1B labor condition applications and PERM certifications6 data points25 May 2026 to 1 Jun 2026
  • Federal lobbying disclosures (LDA)1 record, 96 data points1 Jan 2018 to 30 Sep 2026
  • SEC Form 13F institutional holdings15 records, 261 data points30 Sep 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)190 records13 Jan 2016 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)918 data points31 Dec 2006 to 30 Oct 2026
  • SEC Form 4 insider transactions50 records, 168 data points11 Feb 2016 to 9 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4176 data points1 Aug 2018 to 20 Nov 2026
  • Wikipedia pageviews2578 data points1 Nov 2019 to 21 Nov 2026